Rchr
J-GLOBAL ID:200901057598326029   Update date: Apr. 14, 2024

Suzuki Hiroyuki

スズキ ヒロユキ | Suzuki Hiroyuki
Affiliation and department:
Job title: Associate Professor
Homepage URL  (1): http://www.md.tsukuba.ac.jp/epatho/
Research field  (2): Pharmacology ,  Experimental pathology
Research keywords  (5): Signal transduction ,  Transcription ,  Stem cell ,  TGF-beta ,  実験病理学
Research theme for competitive and other funds  (24):
  • 2022 - 2025 新規がん遺伝子THG-1の生体機能の解明と分子診断・治療法の開発
  • 2019 - 2022 Role of THG-1 in squamous cell carcinoma development and its application to cancer therapy
  • 2018 - 2020 新規のNrf2活性化メカニズムに着目した扁平上皮がん治療薬の探索
  • 2017 - 2019 Master Regulator of squamous cell carcinoma TSC22D4/THG-1 and its application for medical development
  • 2016 - 2019 Roles of THG-1 in squamous cell carcinoma development
Show all
Papers (136):
  • Guanjie Li, Tomohiro Tanaka, Tsunenori Ouchida, Mika K Kaneko, Hiroyuki Suzuki, Yukinari Kato. Cx1Mab-1: A Novel Anti-mouse CXCR1 Monoclonal Antibody for Flow Cytometry. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2024. 43. 2. 59-66
  • Tsunenori Ouchida, Guanjie Li, Hiroyuki Suzuki, Miyuki Yanaka, Takuro Nakamura, Saori Handa, Tomohiro Tanaka, Mika K Kaneko, Yukinari Kato. PMab-314: An Anti-Giant Panda Podoplanin Monoclonal Antibody. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2024. 43. 2. 53-58
  • Tsunenori Ouchida, Yu Isoda, Tomohiro Tanaka, Mika K Kaneko, Hiroyuki Suzuki, Yukinari Kato. Cx3Mab-4: A Novel Anti-Mouse CXCR3 Monoclonal Antibody for Flow Cytometry. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2024
  • Yuki Okada, Hiroyuki Suzuki, Tomohiro Tanaka, Mika K Kaneko, Yukinari Kato. Epitope Mapping of an Anti-Mouse CD39 Monoclonal Antibody Using PA Scanning and RIEDL Scanning. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2024
  • Tomohiro Tanaka, Hiroyuki Suzuki, Guanjie Li, Mika K Kaneko, Yukinari Kato. C8Mab-21: A Novel Anti-human CCR8 Monoclonal Antibody for Flow Cytometry. 2024
more...
MISC (1):
  • 七宮蓮, 鈴木裕之, 金子美華, 加藤幸成, 加藤幸成. Development of anti-HER2 monoclonal antibodies for gastric cancer. 日本癌学会学術総会抄録集(Web). 2022. 81st
Books (8):
  • あなたのラボから薬を生み出すアカデミア創薬の実践 : all Japan体制の先端技術支援を利用した創薬の最前線
    羊土社 2024 ISBN:9784758104166
  • がんゲノム医療時代の分子腫瘍学
    文光堂 2022
  • TGF-β
    2009
  • TGF-betaシグナル伝達系とがん治療
    南山堂 2008
  • TGF-βシグナル伝達とがん治療
    がんの分子標的治療 2008
more...
Lectures and oral presentations  (33):
  • THG-1 overexpression stabilizes β-catenin via antagonizing NRBP1 in esophageal squamous cell carcinoma
    (第79回日本癌学会学術総会 2020)
  • THG-1/TSC22D4による細胞老化の制御
    (第79回日本癌学会学術総会 2020)
  • THG-1はHIF-1alphaの安定化を介して腫瘍の進行を促進する
    (第3回がん三次元培養研究会 2019)
  • Regulation of c-MYC transcriptional activity by transforming growth factor-beta 1-stimulated clone 22
    (第78回日本癌学会学術総会 2019)
  • Screening of macrocyclic peptide against CD44
    (第78回日本癌学会学術総会 2019)
more...
Education (3):
  • - 2001 The University of Tokyo Graduate School, Division of Pharmaceutical Sciences
  • - 1998 The University of Tokyo Graduate School, Division of Pharmaceutical Sciences
  • - 1996 The University of Tokyo Faculty of Pharmaceutical Science
Professional career (1):
  • 博士(薬学) (東京大学)
Work history (5):
  • 2021/08 - 現在 東北大学 大学院医学系研究科 分子薬理学分野 准教授
  • 2012/04/01 - 2021/07/31 筑波大学 医学医療系 准教授
  • 2007/04/01 - 2012/03/31 筑波大学 大学院人間総合科学研究科 助教
  • 2004/04/01 - 2007/03/31 筑波大学 大学院人間総合科学研究科 助手
  • 2001/04/01 - 2004/03/31 日本学術振興会 特別研究員PD
Awards (6):
  • 2012/11 - がん研究振興財団 研究助成金
  • 2008/12 - 安田記念医学財団 若手癌研究助成
  • 2007/11 - 武田科学振興財団 武田科学振興財団 薬学系研究奨励金
  • 2007/02/11 - Nagoya International Cencer Treatment Symposium BMS Award in 2007
  • 2006/03 - 上原記念生命科学財団 上原記念生命科学財団研究奨励金
Show all
Association Membership(s) (5):
日本薬理学会 ,  The Molecular Biology Society of Japan ,  THE JAPANESE SOCIETY OF PATHOLOGY ,  The Japanese Cancer Association ,  THE JAPANESE ASSOCIATION FOR MOLECULAR TARGET THERAPY OF CANCER
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page